The FamiCord Group strengthens its position in Turkey

FamiCord Group has concluded an investment agreement regarding the purchase of shares in the Turkish stem cell bank which has operated so far within the structure of the Acıbadem Healthcare Group.

FamiCord group has now 70% of shares in the newly created Famicord – Acibadem company. The company was formed from a separate part of the enterprise with the Acıbadem Healthcare Group, to which the scope of activities including processing, testing and storage of cord blood was transferred. The remaining 30% of shares will be owned by the Acıbadem Healthcare Group. The purchase is financed from the resources acquired within a private subscription of PBKM shares which took place last year.

Recently added

06 September 2024 Dr Tomasz Baran – FamiCord Vicepresident – speaks on cord blood banking at world’s largest cord blood conference Tomasz Baran, MD, MBA, Vice President of FamiCord Group, recently shared his expertise on cord blood banking at the world’s largest cord blood conference... Read more
15 July 2024 Expanison of cord blood stem cells as a chance for cancer patients Cord blood stem cells are used in medicine for treatment of over 80 different diseases such as leukemias, lymphomas and sickle cell anaemia for over 30 years. It has also been proven that... Read more